ESC Premium Access

One-year echocardiographic outcomes of transcatheter aortic valve implantation with or without predilatation of the aortic valve: Insights from the multicenter, randomized DIRECT trial.

Congress Presentation

About the speaker

Doctor Maria Karmpalioti

Hippokration General Hospital, Athens (Greece)
0 follower

8 more presentations in this session

Prognosis and clinical outcomes after TAVI, regarding the extravalvular cardiac damage defined by echocardiography prior the procedural.

Speaker: Doctor J. Borrego Rodriguez (Bilbao, ES)


Flow rate and stroke volume index as predictors of mortality in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor S. Abdelrazek (Bad Krozingen, DE)


The five-beat averaged method of assessing aortic stenosis in atrial fibrillation significantly underestimates stenosis severity compared to sinus rhythm.

Speaker: Doctor S. Tomlinson (Brisbane, AU)


Prognostic relevance of exercise pulmonary hypertension for new-onset atrial fibrillation in primary mitral regurgitation

Speaker: Doctor K. Teramoto (Osaka, JP)


Ischaemic mitral regurgitation: incidence, clinical and angiographic characteristics of 1000 patients with type 1 myocardial infarction undergoing percutaneous coronary intervention

Speaker: Doctor H. Sharma (Birmingham, GB)


Access the full session

Echocardiography in Valvular Heart Disease: New Insights

Speakers: Doctor M. Karmpalioti, Doctor J. Borrego Rodriguez, Doctor S. Abdelrazek, Doctor S. Tomlinson, Doctor K. Teramoto...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb